title: Induction of a negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells.
abstract: The somatostatin receptor subtype sst2 mediates both activation of a tyrosine phosphatase activity and inhibition of cell proliferation induced by somatostatin analogues. In the absence of exogenous ligand, expression of sst2 in NIH 3T3 cells resulted in inhibition of cell growth. Polymerase chain reaction coupled to reverse transcription demonstrated that expression of sst2 in NIH 3T3 cells stimulated the expression of preprosomatostatin mRNA accompanied by a production of immunoreactive somatostatin-like peptide which corresponded predominantly to somatostatin 14. Moreover anti-somatostatin antibodies suppressed sst2-promoted inhibition of cell proliferation. Inhibition of cell proliferation associated with increased secretion of somatostatin-like immunoreactivity was also observed after expression of sst2 in human pancreatic tumor cells BxPC3 devoid of endogenous receptors. In addition, expression of sst2 in NIH 3T3 cells was associated with constitutive activation of tyrosine phosphatase PTP1C that resulted from enhanced expression of the protein. Blocking of PTP1C tyrosine phosphatase activity with orthovanadate or that of PTP1C protein with antisense PTP1C oligonucleotides decreased the sst2-induced inhibition of cell proliferation. These results, taken together, show that expression of sst2 in NIH 3T3 cells generated a negative autocrine loop by stimulating sst2 ligand production and amplifying PTP1C sst2-transducer. Sst2/ligand may function as a determinant factor involved in the negative growth control of cells.
authors.affiliation: INSERM U151, Institut Louis Bugnard, CHU Rangueil, Toulouse, France.
authors.forename: I
authors.initials: I
authors.lastname: Rauly
authors.forename: N
authors.initials: N
authors.lastname: Saint-Laurent
authors.forename: N
authors.initials: N
authors.lastname: Delesque
authors.forename: L
authors.initials: L
authors.lastname: Buscail
authors.forename: J P
authors.initials: JP
authors.lastname: Estéve
authors.forename: N
authors.initials: N
authors.lastname: Vaysse
authors.forename: C
authors.initials: C
authors.lastname: Susini
mesh_terms: D016475:3T3 Cells; D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D002850:Chromatography, Gel; D017931:DNA Primers; D004791:Enzyme Inhibitors / Q000494:pharmacology; D015870:Gene Expression; D006801:Humans; D007700:Kinetics; D051379:Mice; D008969:Molecular Sequence Data; D016376:Oligonucleotides, Antisense / Q000494:pharmacology; D010190:Pancreatic Neoplasms; D016133:Polymerase Chain Reaction; D011498:Protein Precursors / Q000096:biosynthesis*; D017027:Protein Tyrosine Phosphatases / Q000037:antagonists & inhibitors / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis / Q000096:biosynthesis; D017481:Receptors, Somatostatin / Q000096:biosynthesis* / Q000378:metabolism; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000378:metabolism; D015398:Signal Transduction; D013004:Somatostatin / Q000032:analysis / Q000096:biosynthesis*; D013997:Time Factors; D014407:Tumor Cells, Cultured; D014638:Vanadates / Q000494:pharmacology
chemical_list: D017931:DNA Primers; D004791:Enzyme Inhibitors; D016376:Oligonucleotides, Antisense; D011498:Protein Precursors; D012333:RNA, Messenger; D017481:Receptors, Somatostatin; D011994:Recombinant Proteins; D014638:Vanadates; D013004:Somatostatin; C093733:somatostatin receptor 2; D017027:Protein Tyrosine Phosphatases